[EN] INHIBITORS OF HCV NS5A<br/>[FR] INHIBITEURS DE NS5A DE VHC
申请人:PRESIDIO PHARMACEUTICALS INC
公开号:WO2011150243A1
公开(公告)日:2011-12-01
Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
本文提供了用于抑制丙型肝炎的化合物、药物组合和联合疗法。
INHIBITORS OF HCV NS5A
申请人:Li Leping
公开号:US20130296311A1
公开(公告)日:2013-11-07
Provided herein are compounds, pharmaceutical compositions and combination therapies for inhibition of hepatitis C.
本文提供了用于抑制丙型肝炎的化合物、药物组合物和联合治疗方案。
NOVEL BETULINIC PROLINE IMIDAZOLE DERIVATIVES AS HIV INHIBITORS
申请人:HETERO RESEARCH FOUNDATION
公开号:US20170129916A1
公开(公告)日:2017-05-11
The invention relates to novel betulinic proline substituted derivatives, related compounds, and pharmaceutical compositions useful for the therapeutic treatment of viral diseases and particularly HIV mediated diseases.
Grafting Bis(heteroaryl) Motifs into Ring Structures
作者:Chirag N. Apte、Diego B. Diaz、Timur Adrianov、Andrei K. Yudin
DOI:10.1002/ejoc.202000838
日期:2020.8.23
(N‐isocyanimino)phosphorane has been utilized to synthesize bis(heteroaryl) motifs from a wide range of azoleamines and glyoxals in a variety of ring sizes, ranging from medium‐sized rings to macrocycles. The macrocycles are synthesized in a facile manner from unfunctionalized linear histidine‐terminated peptides and show a high degree of conformational rigidity over their homodetic counterparts. This